About
Somryst is a groundbreaking prescription digital therapeutic (PDT) and the first of its kind to receive FDA clearance for treating chronic insomnia in adults 22 and older. Unlike sleep aids or medications, Somryst works by retraining the brain's sleep patterns using a structured, evidence-based program rooted in Cognitive Behavioral Therapy for Insomnia (CBT-I). The program consists of 6 focused training cores, requiring just 45–60 minutes per week plus a few minutes daily for completing a personalized sleep diary. The full program spans 6 to 9 weeks and is designed to fit seamlessly into everyday life via a smartphone or tablet app. Clinical research supporting Somryst and its predecessor (SHUTi) has demonstrated durable, persistent results at both 6-month and 12-month follow-ups. Somryst is prescribed by healthcare providers and is intended for US residents. It is developed by Nox Medical and was awarded Best Digital Health Product in 2020. Key techniques include building sharper sleep windows, stimulus control, sleep restriction therapy, and detailed sleep diary tracking. Somryst is ideal for adults struggling with long-term insomnia who seek a non-pharmacological, clinically validated alternative to sleep medications.
Key Features
- FDA-Cleared Prescription Digital Therapeutic: Somryst is the first and only FDA-cleared digital therapeutic specifically indicated for treating chronic insomnia in adults 22 and older, providing medical-grade credibility.
- 6 Structured CBT-I Training Cores: The program delivers six evidence-based training modules grounded in Cognitive Behavioral Therapy for Insomnia (CBT-I), addressing the root causes of chronic sleeplessness.
- Personalized Daily Sleep Diary: Users complete a brief daily sleep diary that tracks patterns and informs the program's adaptive recommendations, keeping the therapy tailored to individual progress.
- Clinically Proven Long-Term Results: Clinical studies show persistent improvement at 6- and 12-month follow-ups, making Somryst a durable solution rather than a temporary fix.
- Mobile-First, Convenient Delivery: Accessible on smartphones and tablets, Somryst fits into daily routines with only 45–60 minutes of weekly engagement over a 6–9 week program.
Use Cases
- Adults with chronic insomnia seeking a non-medication, clinically validated treatment option prescribed by their doctor.
- Patients who have tried or want to avoid sleep medications due to concerns about dependency or side effects.
- Healthcare providers looking to prescribe an FDA-cleared digital therapeutic as a first-line or adjunct treatment for chronic insomnia.
- Individuals who prefer a self-guided, app-based therapy program they can complete at home on their own schedule.
- Patients enrolled in integrative or behavioral health programs who need a structured CBT-I intervention with documented clinical outcomes.
Pros
- Non-Pharmacological Treatment: Somryst offers a drug-free alternative to sleep medications, eliminating risks of dependency, side effects, and grogginess associated with traditional sleep aids.
- Strong Clinical Evidence: Backed by rigorous clinical research demonstrating sustained results at 6 and 12 months, giving users and clinicians confidence in its efficacy.
- Convenient and Accessible: The app-based format allows patients to complete therapy on their own schedule, from the comfort of home, without frequent clinic visits.
- Award-Winning Digital Health Product: Recognized as Best Digital Health Product in 2020, reflecting its innovation and impact in the digital therapeutics space.
Cons
- Requires a Prescription: Somryst is not available over the counter — users must obtain a prescription from a healthcare provider, adding a barrier to access.
- US-Only Availability: The platform is currently intended for US residents only, limiting access for international users suffering from chronic insomnia.
- Requires Commitment Over Several Weeks: The 6–9 week program demands consistent daily and weekly engagement, which may be challenging for users seeking immediate relief.
Frequently Asked Questions
What is Somryst and how does it work?
Somryst is an FDA-cleared prescription digital therapeutic for chronic insomnia. It delivers a structured CBT-I (Cognitive Behavioral Therapy for Insomnia) program through 6 training cores over 6–9 weeks via a smartphone or tablet app, helping retrain the brain's sleep patterns without medication.
Do I need a prescription to use Somryst?
Yes, Somryst is a prescription digital therapeutic. You must be prescribed Somryst by a licensed healthcare provider before you can access and use the program.
How long does the Somryst program take?
The program runs 6 to 9 weeks, requiring approximately 45–60 minutes per week of focused training plus a few minutes each day to complete a sleep diary.
Is Somryst scientifically proven to work?
Yes. Clinical studies have demonstrated that Somryst produces persistent improvements in chronic insomnia, with results maintained at both 6-month and 12-month follow-up assessments.
Who is Somryst intended for?
Somryst is indicated for adults aged 22 and older who suffer from chronic insomnia. It is intended for use by US residents and should be used under the guidance of a healthcare provider.
